KLOW
Free Reconstitution Starter Kit W/ Select Purchase
KLOW is a multi-peptide blend combining TB-500 (10 mg), BPC-157 (10 mg), KPV (10 mg), and GHK-Cu (50 mg) for a total of 80 mg per vial. TB-500 (synthetic thymosin beta-4) promotes wound healing, angiogenesis, and tissue repair. BPC-157 exhibits regenerative properties with preclinical evidence supporting tendon, ligament, and muscle healing. KPV is an anti-inflammatory tripeptide that modulates NF-κB signaling. GHK-Cu supports collagen synthesis, wound healing, and tissue regeneration. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Syringe Math Reference
With 3.0 mL reconstitution volume and 80 mg total peptide:
Total concentration: 26.67 mg/mL (26,667 mcg/mL)
TB-500: 3.33 mg/mL → 33.3 mcg per unit
BPC-157: 3.33 mg/mL → 33.3 mcg per unit
KPV: 3.33 mg/mL → 33.3 mcg per unit
GHK-Cu: 16.67 mg/mL → 166.7 mcg per unit
1 unit (0.01 mL) = 33.3 mcg each of TB-500, BPC-157, KPV + 166.7 mcg GHK-Cu
Dosing Protocol
Suggested daily titration approach.
Start: 7.5 units daily (0.075 mL) for initial assessment period.
Increase: Progress to 15 units by Week 3, then 22.5 units by Week 5 as tolerated.
Maintenance: 15 units daily for extended protocols.
Frequency: Once per day (subcutaneous).
Cycle Length: 8–12 weeks; optional extension to 16 weeks.
Timing: Any consistent time; rotate injection sites.
Important Notes
Practical considerations for consistency and safety.
Use new sterile insulin syringes for each injection; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation to maintain consistency.
This multi-peptide blend may provide broader regenerative support than single-peptide protocols.
How This Works
KLOW combines four peptides with complementary mechanisms of action:
TB-500 (Thymosin Beta-4): Promotes angiogenesis, cell migration, and tissue repair by regulating actin, a key protein in cell structure. Preclinical studies demonstrate accelerated wound healing, reduced inflammation, and tissue regeneration.
BPC-157: A gastric pentadecapeptide that supports tendon, ligament, and muscle healing through enhanced angiogenesis and growth factor modulation. Animal studies show favorable tissue repair outcomes.
KPV: A C-terminal tripeptide fragment of α-MSH with potent anti-inflammatory properties. It inhibits NF-κB signaling and reduces pro-inflammatory cytokines without melanotropic effects.
GHK-Cu: A naturally occurring copper peptide that stimulates collagen and elastin synthesis, promotes wound healing, and modulates gene expression related to tissue remodeling.
Potential Benefits & Side Effects
Observations from preclinical and early-stage research.
Potential Benefits
Accelerated tissue repair and wound healing through multiple complementary pathways.
Reduced inflammation via NF-κB inhibition and cytokine modulation.
Enhanced collagen synthesis and connective tissue support.
Promotion of angiogenesis and improved blood flow to healing tissues.
Potential support for musculoskeletal recovery and joint health.
Possible Side Effects
Mild injection-site reactions (redness, irritation) may occur with subcutaneous administration.
Occasional lightheadedness reported with some peptides due to vasodilatory effects.
Limited human clinical data; most safety observations derive from preclinical studies.
Lifestyle Factors
Complementary strategies for best outcomes.
Pair with a balanced, protein-forward diet tailored to support tissue repair and recovery.
Combine resistance training and mobility work to reinforce musculoskeletal adaptations.
Prioritize sleep and stress management to optimize the body’s natural regenerative processes.
Stay well-hydrated to support peptide absorption and overall metabolic function.
Injection Technique
General subcutaneous guidance from clinical best-practice resources.
Clean the vial stopper and skin with alcohol; allow to dry completely.
Pinch a skin fold; insert the needle at 45–90° into subcutaneous tissue.
Do not aspirate for subcutaneous injections; inject slowly and steadily.
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
Apply gentle pressure after withdrawal; do not massage the injection site.
